Insmed
INSM
#1050
Rank
HK$181.22 B
Marketcap
HK$836.11
Share price
-1.82%
Change (1 day)
3.50%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -HK$8.61 Billion

According to Insmed's latest financial reports the company's current earnings are HK$0.81 Billion. In 2025 the company made an earning of -HK$9.37 Billion a decrease over its 2024 earnings that were of -HK$6.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$8.61 Billion-8.14%
2025 -HK$9.37 Billion43.91%
2024 -HK$6.51 Billion23.71%
2023 -HK$5.26 Billion45.77%
2022 -HK$3.61 Billion15.83%
2021 -HK$3.12 Billion50.19%
2020 -HK$2.08 Billion16.4%
2019 -HK$1.79 Billion-23.9%
2018 -HK$2.35 Billion59.35%
2017 -HK$1.47 Billion8.52%
2016 -HK$1.36 Billion47.25%
2015 -HK$0.92 Billion34.53%
2014 -HK$0.69 Billion58.83%
2013 -HK$0.44 Billion35.14%
2012 -HK$0.32 Billion-31.92%
2011 -HK$0.47 Billion854.92%
2010 -HK$48.98 Million-105.22%
2009 HK$0.93 B-905.06%
2008 -HK$0.12 Billion-27.31%
2007 -HK$0.17 Billion-62.41%
2006 -HK$0.43 Billion98.19%
2005 -HK$0.22 Billion0.03%
2004 -HK$0.22 Billion159.07%
2003 -HK$83 Million-69.31%
2002 -HK$0.28 Billion
2000 -HK$0.25 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$123.75 B-1,532.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
HK$84.11 B-1,073.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$39.68 B-559.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$0.19 B-102.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$0.19 Billion-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-HK$0.19 Billion-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA